What Cosyne Therapeutics say about themselves
“CoSyne Therapeutics is a vertically integrated AI drug discovery company aiming to bring speed to precision medicine through polymathic AI to help patients with under-served diseases of the brain.”
Cosyne Therapeutics Limited
- Incorporated
- 1 February 2021 (5 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Accounts type
- Total exemption full
- Region
- Greater London
- Address
- 2 Sheraton StreetWework Medius HouseLondonW1F 8BH
Website & contact details
- Website
Filing status
- Accounts due
- 30 November 2027
- Last accounts
- 28 February 2026
- Conf. stmt due
- 14 February 2027
- Last conf. stmt
- 31 January 2026
Officers
This list may be incomplete. See all officers on Companies House
Officer details are public data from the Companies House register.
Director · Appointed 30 July 2026
British
Born August 1993 (33)
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Former controllers (3)
16 May 2022
Ceased Louwai Muhammed — Owns 25–50% of shares
16 May 2022
Ceased Michael Johnson — Owns 25–50% of shares
16 May 2022
Ceased Liisi Laaniste — Owns 25–50% of shares
Financials
Balance sheet as at 28 February 2026 · total exemption full accounts
- Net Assets
- (£472,854)
- Cash
- £1,877,184
- Employees
- 18
- Debt Ratio
- 118%
- Current Ratio
- 18.1x
Trend
Net Assets
Balance sheet detail
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Fixed Assets | £172,257 | £175,463 | £296,637 | £94,552 | £14,590 |
| Current Assets | £2,492,532 | £3,693,293 | £2,265,542 | £4,804,991 | £109,730 |
| Cash | £1,877,184 | £2,803,870 | £1,644,388 | £4,646,062 | £54,277 |
| Creditors (< 1 year) | £137,643 | £254,179 | £283,490 | £77,878 | £5,216 |
| Creditors (> 1 year) | £3,000,000 | £1,500,000 | £249,997 | ||
| Net Current Assets | £2,354,889 | £3,439,114 | £1,982,052 | £4,727,113 | £104,514 |
| Net Assets | (£472,854) | £2,114,577 | £2,278,689 | £4,821,665 | (£130,893) |
| Shareholder Funds | (£472,854) | £2,114,577 | £2,278,689 | £4,821,665 | (£130,893) |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 29 October 2026 | Statement of capital | |||
| 29 October 2026 | Insolvency filing | |||
| 29 October 2026 | Share capital filing | |||
| 29 October 2026 | Resolutions | |||
| 16 September 2026 | Memorandum and Articles of Association |
Some other companies at this address
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →